Provided by Tiger Trade Technology Pte. Ltd.

CareDx

49.60
+0.63001.29%
Post-market: 50.000.4000+0.81%18:53 EDT
Volume:825.87K
Turnover:40.96M
Market Cap:2.57B
PE:23.39
High:51.37
Open:49.55
Low:48.40
Close:48.97
52wk High:53.67
52wk Low:12.37
Shares:51.73M
Float Shares:48.55M
Volume Ratio:0.62
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.12
EPS(LYR):-0.4007
ROE:29.49%
ROA:-0.25%
PB:6.03
PE(LYR):-123.77

Loading ...

CareDx publishes 2025 annual report

Reuters
·
May 01

CareDx announces annual shareholder meeting via webcast

Reuters
·
May 01

CareDx publishes ESG report outlining 2025 environmental, social and governance performance

Reuters
·
Apr 29

CareDx price target raised to $28 from $26 at BTIG

TIPRANKS
·
Apr 29

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), Stryker (SYK) and CareDx (CDNA)

TIPRANKS
·
Apr 29

CareDx Is Maintained at Buy by BTIG

Dow Jones
·
Apr 29

Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Apr 29

Stock Track | CareDx Plunges 8.58% in Post-Market as Acquisition of Naveris Overshadows Strong Q1 Results

Stock Track
·
Apr 29

CareDx files automatic mixed securities shelf

TIPRANKS
·
Apr 29

CareDx raises FY26 revenue view to $447M-$465M from $420M-$444M

TIPRANKS
·
Apr 29

GUIDANCE: (CDNA) CareDx Now Expects Full Year 2026 Revenue Range $447 Million - $465 Million, vs. FactSet Est of $432 Million

MT Newswires Live
·
Apr 29

CareDx Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Apr 29

CareDx Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 29

CareDx to Acquire Naveris, Expanding Oncology Diagnostics

TIPRANKS
·
Apr 29

Stock Track | CareDx Plunges 5.07% After-Hours Despite Strong Q1 Results as Acquisition of Naveris Raises Investor Concerns

Stock Track
·
Apr 29

CareDx agrees to buy Naveris for USD 160 million upfront, plus milestones

Reuters
·
Apr 29

CareDx reports Q1 EPS 34c, consensus 13c

TIPRANKS
·
Apr 29

CareDx Announces Agreement to Acquire Naveris, a Leader in Viral-Mediated Cancer Mrd Surveillance Testing

THOMSON REUTERS
·
Apr 29

CareDx Inc - Deal Includes $160 Mln up-Front Cash, up to $100 Mln in Milestone Payments

THOMSON REUTERS
·
Apr 29

CareDx Inc - Announces Agreement to Buy Naveris

THOMSON REUTERS
·
Apr 29